ESMO Congress 2026
| Details of the poster presentation are as follows: |
||
| Abstract title: |
Leronlimab (LRM) in combination with trifluridine/tipiracil (TAS-102) plus bevacizumab (BEV) in metastatic colorectal cancer (mCRC): The phase 2 CLOVER study |
|
| Presenter: |
Benjamin Weinberg, M.D., Associate Professor at Georgetown University |
|
| Date and Time: |
Sunday, October 25, 2026, 12:00-12:45 p.m. CET (local time) |
|
| Poster ID: |
820P |
|
| Location: | Poster Area, Hall 5, IFEMA Madrid | |